Literature DB >> 19185883

Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs?

Nachum Vaisman1, Michal Lusaus, Beatrice Nefussy, Eva Niv, Doron Comaneshter, Ron Hallack, Vivian E Drory.   

Abstract

BACKGROUND AND AIMS: Nutritional status is a prognostic factor for survival in amyotrophic lateral sclerosis (ALS) patients. We investigated the contribution of some of the components contributing to resting energy expenditure (REE) in order to determine whether potentially higher energy needs should be considered for these patients.
METHODS: Thirty three ALS patients and 33 age- and gender-matched healthy controls participated. REE was measured by an open-circuit indirect calorimeter, body composition by dual energy X-ray absorptiometry, and estimated caloric intake by 7-day food records.
RESULTS: Patients had lower body mass indices and lower lean body mass (LBM) than healthy controls. REE values (as a percentage of predicted) was similar but increased when normalized by LBM (P<0.001). LBM and REE decreased while REE/LBM increased in ten patients who were reassessed 6 months later. A model for predicting measured REE was constructed based on the different components, with 86% prediction of its variability.
CONCLUSIONS: ALS is associated with increased REE. Various factors, such as poor caloric intake and mechanical ventilation, may mask this tendency. All the above parameters need to be considered during nutritional intervention to prevent additional muscle loss.

Entities:  

Mesh:

Year:  2009        PMID: 19185883     DOI: 10.1016/j.jns.2008.12.027

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  29 in total

Review 1.  PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond.

Authors:  Taiji Tsunemi; Albert R La Spada
Journal:  Prog Neurobiol       Date:  2011-11-09       Impact factor: 11.685

Review 2.  Physiological changes in neurodegeneration - mechanistic insights and clinical utility.

Authors:  Rebekah M Ahmed; Yazi D Ke; Steve Vucic; Lars M Ittner; William Seeley; John R Hodges; Olivier Piguet; Glenda Halliday; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2018-03-23       Impact factor: 42.937

Review 3.  AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis.

Authors:  Nirma D Perera; Bradley J Turner
Journal:  Neurochem Res       Date:  2015-07-23       Impact factor: 3.996

4.  Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status.

Authors:  Christian Lunetta; Andrea Lizio; Lucio Tremolizzo; Massimiliano Ruscica; Chiara Macchi; Nilo Riva; Patrick Weydt; Ettore Corradi; Paolo Magni; Valeria Sansone
Journal:  J Neurol       Date:  2018-10-22       Impact factor: 4.849

5.  Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival.

Authors:  R M Ahmed; J Caga; E Devenney; S Hsieh; L Bartley; E Highton-Williamson; E Ramsey; M Zoing; G M Halliday; O Piguet; J R Hodges; M C Kiernan
Journal:  J Neurol       Date:  2016-06-03       Impact factor: 4.849

6.  Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Sagit Golko-Perez; Silvia Mandel; Tamar Amit; Lana Kupershmidt; Moussa B H Youdim; Orly Weinreb
Journal:  Neurotox Res       Date:  2015-11-18       Impact factor: 3.911

Review 7.  The effects of diet and sex in amyotrophic lateral sclerosis.

Authors:  J A Pape; J H Grose
Journal:  Rev Neurol (Paris)       Date:  2020-03-05       Impact factor: 2.607

8.  Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort.

Authors:  Valentina Gallo; Petra A Wark; Mazda Jenab; Neil Pearce; Carol Brayne; Roel Vermeulen; Peter M Andersen; Goran Hallmans; Andreas Kyrozis; Nicola Vanacore; Mariam Vahdaninia; Verena Grote; Rudolf Kaaks; Amalia Mattiello; H Bas Bueno-de-Mesquita; Petra H Peeters; Ruth C Travis; Jesper Petersson; Oskar Hansson; Larraitz Arriola; Juan-Manuel Jimenez-Martin; Anne Tjønneland; Jytte Halkjær; Claudia Agnoli; Carlotta Sacerdote; Catalina Bonet; Antonia Trichopoulou; Diana Gavrila; Kim Overvad; Elisabete Weiderpass; Domenico Palli; J Ramón Quirós; Rosario Tumino; Kay-Tee Khaw; Nicholas Wareham; Aurelio Barricante-Gurrea; Veronika Fedirko; Pietro Ferrari; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Heiner Boeing; Matthaeus Vigl; Lefkos Middleton; Elio Riboli; Paolo Vineis
Journal:  Neurology       Date:  2013-02-06       Impact factor: 9.910

9.  Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapies.

Authors:  Beatrice Nefussy; Vivian E Drory
Journal:  EPMA J       Date:  2010-06-09       Impact factor: 6.543

10.  Hypermetabolism associated with worse prognosis of amyotrophic lateral sclerosis.

Authors:  Jiayu Fu; Ji He; Wei Zhao; Chuan Ren; Ping Liu; Lu Chen; Dan Li; Lu Tang; Lequn Zhou; Yixuan Zhang; Xinran Ma; Gaoqi Zhang; Nan Li; Dongsheng Fan
Journal:  J Neurol       Date:  2021-07-18       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.